Proceedings.

CanadaBis Capital Inc., 1998643 Alberta Ltd., Stigma Pharmaceuticals Inc., 2103157 Alberta Ltd., and Full Spectrum Labs Ltd.

Follow
Active
Proceeding
CCAACompanies’ Creditors Arrangement Act, R.S.C. 1985, c. C-36, as amended
File
2601-07007
Filings held26
Last activity27 Aug 2026
On the record157 days
Secured debt$1.21M
OverviewSummary updated

CanadaBis Capital Inc. and four subsidiaries — 1998643 Alberta Ltd., Stigma Pharmaceuticals Inc., 2103157 Alberta Ltd. and Full Spectrum Labs Ltd. — commenced CCAA proceedings in Alberta on April 17, 2026, reporting combined liabilities of $19,250,525 on an unaudited basis against approximately $1,340,000 of available cash as at April 14, 2026. The largest claim is the Canada Revenue Agency's excise tax exposure of approximately $7,621,000; CRA had demanded $5,732,843 within 14 days by letter dated March 4, 2026, received March 25, and threatened enforcement. Connect First Credit Union Ltd. is owed $3,592,324 on a commercial mortgage maturing July 2026 and $631,587 on a $750,000 line of credit, and has waived a debt service coverage covenant breach outstanding since July 31, 2025 only until July 31, 2026. The applicants recorded a net loss of $835,204 for the year ended July 31, 2025.

Proceedings AIAsk this case — answers cite the filings
Ask in plain language. The answer comes only from this case’s filings, each one cited.
Enter to send · Shift+Enter for a new line
Case updates27 dated entries
#Report

The officer filed report no. Third Report. The Applicants continue to operate their cannabis cultivation, processing, and sale business while pursuing a court-approved sale and investment solicitation process (SISP), resulting in a reverse vesting share purchase transaction with 2208318 Alberta Ltd. as Successful Bidder.

Source: Third Report of the Monitor

#Order

The court approved a sale and investment solicitation process. A phase 1 deadline of 2026-07-15. A bid deadline of 2026-08-10.

Source: SISP Notice

#Order

The court approved a sale and investment solicitation process. A phase 1 deadline of 2026-07-15. A bid deadline of 2026-08-10.

Source: SISP Order

#Order

The court approved a sale and investment solicitation process. A phase 1 deadline of 2026-07-15. A bid deadline of 2026-08-10.

Source: SISP Procedures

#Order

CanadaBis Capital Inc., 1998643 Alberta Ltd., Stigma Pharmaceuticals Inc., 2103157 Alberta Ltd., and Full Spectrum Labs Ltd. — CCAA filed, Alberta.

Source: Initial Order

Case update

CanadaBis: the licence is the asset, so the company is what gets sold

Excise duty ran at 41 to 47 per cent of gross revenue and the CRA wanted $5,732,843 in fourteen days. Four months later the sale process produced one bid, from a company whose director sits on the debtor's own board — and because a cannabis licence cannot be assigned, the deal is structured so the licence never moves.

Parties

Debtor

CanadaBis Capital Inc., 1998643 Alberta Ltd., Stigma Pharmaceuticals Inc., 2103157 Alberta Ltd., and Full Spectrum Labs Ltd.

Monitor

FTI

Bench and counselPer the orders and service lists on the record

Bench

JudgeCourtOn this docketCases on record
Justice SimardCourt of King's Bench of Alberta1 order, Aug 202625 cases on record

Counsel of record

PartyCounselFirst seenSource
MonitorFTIFasken Martineau DuMoulin LLP20 Apr 2026Service list · 20 Apr 2026
ApplicantCanadaBis Capital Inc., 1998643 Alberta Ltd., Stigma Pharmaceuticals Inc., 2103157 Alberta Ltd., and Full Spectrum Labs Ltd.Thornton Grout Finnigan LLP20 Apr 2026Service list · 20 Apr 2026
CreditorServus Credit Union / Connect First Credit UnionBurnet Duckworth & Palmer LLP20 Apr 2026Service list · 20 Apr 2026
Capital structureAs asserted in the filings
stated amounts, drawn to scale
#Priority classCreditorAmountSource
3Deemed trusts (CRA and other)Canada Revenue Agency (CRA) · in 926 casesOutstanding excise tax liabilities; quasi-governmental deemed-trust class claim. Figure is approximate as stated ("approximately $7,621,000"). A prior CRA Demand letter dated March 4, 2026 (received March 25, 2026) demanded an exact amount of $5,732,843, payable within 14 days; enforcement threatened absent payment arrangement. — debtor: 1998643 Alberta Ltd. ("199") and the Applicants generally · as of 14 Apr 2026$7.62MOriginating Application
4Secured2208318 Alberta Ltd.Secured loan; principal amount $1,168,000 (outstanding balance includes accrued interest) — debtor: CanadaBis Capital Inc. and its subsidiaries (the Applicants) · as of 14 Apr 2026$1.21MOriginating Application
4SecuredRunway Developments Inc.$650,000 demand loan; security interest not specified in the document — debtor: CanadaBis Capital Inc. and its subsidiaries (the Applicants) · as of 14 Apr 2026$652KOriginating Application
4SecuredConnect First Credit Union Ltd. · in 8 cases$750,000 Line of Credit facility (drawn amount); same lender/facility grouping as Commercial Mortgage — Line of Credit is substantially drawn; subject to same covenant breach/waiver noted for the Commercial Mortgage. — debtor: CanadaBis Capital Inc. and its subsidiaries (the Applicants) · as of 14 Apr 2026$632KOriginating Application
Sale processAs stated in the filings

Approval pendingMonitor declared the Purchaser the Successful Bidder and recommends Court approval of the Subscription AgreementThird Report of the Monitor · 19 Aug 2026

Parties solicited

128

Third Report of the Monitor

Letters of intent

2

Third Report of the Monitor

Bid deadline

10 August 2026

SISP Notice

PurchaserPriceStatusSource
2208318 Alberta Ltd.Related partythe Applicants' business and assets, structured by way of a reverse vesting share purchase transaction · share sale · agreement 19 Aug 2026SealedPurchase Price described only as 'As set forth in the Confidential Report.'Proposedoutside 8 Oct 2026Third Report of the Monitor
AdvisorsFTI Consulting Canada Inc. (sale agent)SISP Procedures
Fees and ratesAs stated in the filings

1 engagement · 1 firmFasken Martineau DuMoulin LLP, 27 Mar – 16 Aug 2026Third Report of the Monitor · 19 Aug 2026

FirmPeriodHoursFeesRatesSource
Fasken Martineau DuMoulin LLPCounsel to the monitor27 Mar – 16 Aug 2026$884stated averageThird Report of the Monitor · 19 Aug 2026
Estate financialsReported figures — never derived
Total liabilities at filing$19.3M

As at 15 Apr 2026 · per Applicants' own statement in the Originating Application (unaudited, stated to satisfy CCAA's $5,000,000 statutory threshold) · Combined total liabilities of all Applicants (CanadaBis Capital Inc., 1998643 Alberta Ltd., Stigma Pharmaceuticals Inc., 2103157 Alberta Ltd., and Full Spectrum Labs Ltd.) — Total assets not stated in this document. Applicants had approximately $1,340,000 in available cash as at April 14, 2026, and trade accounts payable and accrued liabilities in excess of approximately $937,000. Applicants recorded a net loss of $835,204 for fiscal year ended July 31, 2025, and a further net loss of approximately $128,539 for the three-month period ended October 31, 2025.

Professional fees to date

$572K

As at 19 Aug 2026Third Report of the Monitor

Documents
26 filings
DateDocumentFile
Approval and Reverse Vesting OrderPDF
First Affidavit of Dannallyn SalitaPDF
Approval and Reverse Vesting Order and Stay Extension and Termination Order Application
  • Order date 27 August 2026
  • Phase1 deadline 15 July 2026
  • Presiding officer Justice Simard
  • Stay extended to 30 October 2026
PDF
First Affidavit of Jeffrey HolmgrenPDF
Third Report of the Monitor
  • Fee schedule Engagements: Form: report_table · Rows: · Money: Approximate: false · Period: End: 2026-08-16 · Kind: invoice · Quote: From March 27, 2026 to August 16, 2026 · Start: 2026-03-27 · Approval: State: unstated · Averages: —; — · Currency: · Invoices: · Firm text: Fasken Martineau DuMoulin LLP · Firm quote: FASKEN MARTINEAU DuMOULIN LLP · Context quote: CanadaBis Group Fee Summary of the Monitor's Counsel - Fasken Martineau DuMoulin LLP From March 27, 2026 to August 16, 2026
  • Operational summary The Applicants continue to operate their cannabis cultivation, processing, and sale business while pursuing a court-approved sale and investment solicitation process (SISP), resulting in a reverse vesting share purchase transaction with 2208318 Alberta Ltd. as Successful Bidder.
  • Process results 128 solicited · 7 NDAs · 2 LOIs · 2 qualified bids · 2 bids · as of 10 Aug 2026
  • Professional fees $572K · Note: Excludes $28,610.81 in applicable taxes; Fasken (Monitor's legal counsel) fees were $209,481.62 including $184,417.00 in fees, $1,021.71 in disbursements, and $24,043.45 in taxes for the same general period (March 27, 2026 to August 16, 2026). · Party: Monitor (FTI Consulting Canada Inc.) · Period: March 23, 2026 to August 16, 2026
  • + 4 more extracted facts
PDF
SISP Notice
  • Phase1 deadline 15 July 2026
PDF
SISP Order
  • Bid deadline 15 July 2026
  • Order date 10 June 2026
  • Outside date 8 October 2026
  • Phase1 deadline 15 July 2026
  • + 2 more extracted facts
PDF
SISP Procedures
  • Bid deadline 15 July 2026
  • Order date 10 June 2026
  • Outside date 8 October 2026
  • Phase1 deadline 15 July 2026
  • + 3 more extracted facts
PDF
Second Amended and Restated Initial Order
  • Order date 10 June 2026
  • Stay expiry 11 September 2026
PDF
Second Report of the Monitor
  • Sale outcome Sale process approved — The SISP was approved by the Court and is being implemented; no bids received yet
PDF
Bench Brief of the ApplicantsPDF
Book of AuthoritiesPDF
SISP Order and Second ARIO Application
  • Bid deadline 10 August 2026
  • Order date 10 June 2026
  • Phase1 deadline 15 July 2026
  • Stay extended to 11 September 2026
PDF
Second Affidavit of Travis McIntyrePDF
Amended and Restated Initial Order
  • Order date 27 April 2026
  • Stay expiry 11 June 2026
PDF
Bench Brief - Amended and Restated Initial Order
  • Stay extended to 11 June 2026
PDF
First Report of the MonitorPDF
Application - Amended and Restated Initial Order
  • Order date 27 April 2026
  • Stay extended to 11 June 2026
PDF
Service List
  • Counsel Fasken Martineau Dumoulin LLP
PDF
Affidavit of Travis McIntyre
  • Financial position Assets $24.3M · Liabilities $19.3M · as at 31 Jan 2026 · per book value, per the CanadaBis Group's unreleased/unaudited Internal Financial Statements as at January 31, 2026; affiant notes book value of assets (particularly inventory) likely does not reflect realizable value in a liquidation or distressed sale scenario · Applicants (CanadaBis Capital Inc., Stigma Pharmaceuticals Inc., 1998643 Alberta Ltd., 2103157 Alberta Ltd., Full Spectrum Labs Ltd.) - aggregate/consolidated basis — Assets table (Total Assets $24,322,362) appears on original page 19; Liabilities table (Total liabilities $19,250,525) spans original pages 21-22.
  • Secured creditors $3.59M · Note: CanadaBis has been in default of the 1.40:1 debt service coverage ratio covenant since July 31, 2025; Connect First granted a waiver of this default until July 31, 2026 (Nov 12, 2025 waiver). Commercial Mortgage matures July 2026; monthly P&I payment $60,490. · Page: 24 · As of: 2026-04-14 · Debtor: CanadaBis Capital Inc. (borrower); guaranteed by 199, 210, Full Spectrum Labs Ltd., Stigma Pharmaceuticals Inc. and Goldstream Cannabis Inc. · Creditor: Connect First Credit Union Ltd. · Security: Commercial Mortgage (facility limit $8,850,000, part of $9,600,000 Credit Facility) secured by: Facility Mortgage and Facility Rent Assignment over the Facility (owned by 199) and 199 GSA; CanadaBis GSA (all present/after-acquired personal property, registered AB/BC/SK/ON); unlimited guarantees and postponements from 199, 210, Full Spectrum, Stigma Pharmaceuticals and Goldstream, each secured by site/entity-specific GSAs (199 GSA, 210 GSA/Leva Mortgage/Leva Rents Assignment, Full Spectrum GSA, Stigma Pharmaceuticals GSA, Goldstream GSA); also secured by assignment/postponement to Connect First of related-party debt owed by CanadaBis: $990,000 principal owed to 220 (220 Debt Assignment) and $650,000 principal owed to Runway Developments Inc. (Runway Debt Assignment)
PDF
CCAA FAQsPDF
Initial Order
  • Applicant CanadaBis Capital Inc., 1998643 Alberta Ltd., Stigma Pharmaceuticals Inc., 2103157 Alberta Ltd., and Full Spectrum Labs Ltd.
  • Appointee FTI Consulting Canada Inc.
  • Appointee role Monitor
  • Commencement date 17 April 2026
  • + 4 more extracted facts
PDF
List of Known CreditorsPDF
Notice to CreditorsPDF
Originating Application
  • Applicant CANADABIS CAPITAL INC., 1998643 ALBERTA LTD., STIGMA PHARMACEUTICALS INC., 2103157 ALBERTA LTD., AND FULL SPECTRUM LABS LTD.
  • Appointee FTI Consulting Canada Inc.
  • Appointee role monitor
  • Court COURT OF KING’S BENCH OF ALBERTA
  • + 3 more extracted facts
PDF
Pre-Filing Report of the Proposed Monitor
  • Secured creditors Note: No aggregate outstanding balance stated for these serialized-equipment financings. NFS Pre-Roll Lease equipment was bought out by 199 for $33,009.98 (Feb 26, 2026) and the equipment resold to C-Flikinger for $70,631.36; however, the related PPSA registration remains active as at April 14, 2026, notwithstanding the buyout. · Page: 12 · As of: 2026-04-14 · Debtor: 1998643 Alberta Ltd. (199) · Creditor: PPSA equipment financiers (PMSI class) · Currency: CAD · Security: NFS Leasing Canada Ltd. - CANTOS pre-roll manufacturing equipment lease (total equipment cost ~$741,641.04, financing ~$593,312.83, PPSA registered March 31, 2023); NFS Leasing Canada Ltd. - Pre-Roll Lease (total equipment cost ~$382,653, financing ~$286,989.75, PPSA registered Oct 27, 2022); 2079479 Alberta Ltd. - Extraction and Processing Lease (6-year term from Jan 31, 2021, monthly payments ~$11,991); Royal Bank of Canada - PPSA registration March 10, 2023 against 2018 Mercedes Benz G Class; RCAP Leasing Inc. - PPSA registration March 24, 2023 against photocopier equipment; Ford Credit Canada Company - PPSA registration March 26, 2025 against 2025 Ford F350
PDF

Filing titles, dates, and extracted key facts are public.

CiteProceedings., “CanadaBis Capital Inc., 1998643 Alberta Ltd., Stigma Pharmaceuticals Inc., 2103157 Alberta Ltd., and Full Spectrum Labs Ltd.” (CCAA), Court of King's Bench of Alberta. Retrieved 20 September 2026, https://proceedings.ca/case/canadabis-capital-inc-1998643-alberta-ltd-stigma-pharmaceuticals-inc-2103157-alb

Sources last checked · summary updated 8 August 2026 · Report a correction · Printed from proceedings.ca/case/canadabis-capital-inc-1998643-alberta-ltd-stigma-pharmaceuticals-inc-2103157-alb

Facts and summaries are extracted automatically from the court filings linked on each page; the filings remain the authoritative record. Suggested corrections are reviewed against the source filings.